A new Congress convened last week and legislation is starting to flow.
One such bill is the Biological Implant Tracking and Veteran Safety Act of 2017, which passed the House on January 3, the first day of the session.
The bill would require the U.S. Veteran’s Administration to implement a tracking system for “any human cell, tissue, or cellular or tissue-based product or animal product,” as defined by FDA, from “human donor or animal source to implantation.” The purpose of a tracking system would be to facilitate any recall.
The bill would also limit the Veteran’s Administration to using biological implants from a vendor that also uses a tracking system and that is registered with FDA. The vendor must use biological material “only from tissue processors that maintain active accreditation with the American Association of Tissue Banks or a similar national accreditation specific to biological implants.”
A previous version of this bill passed the House last April. This version now goes to the Senate.